Children with inflammatory bowel disease who contract COVID-19 generally have mild disease, according to study results.

In her presentation at Crohn’s and Colitis Congress, Erica J. Brenner, MD, from the University of North Carolina, said that her group’s findings show that in in this patient group, physicians should treat IBD “first and foremost.”

“The aims of this study were two define the impact of COVID-19 on children and adolescents with inflammatory bowel disease,” she said. “We wanted to evaluate associations between comorbidities, IBD

Full Article: